https://www.selleckchem.com/pr....oducts/BIRB-796-(Dor
7 months without (p0.0001). Age 70 years, CA19-9 200 U/mL, PDAC and N2 status were significantly associated with worse survival in a multivariable analysis. PALN status and LNR were not independent prognostic factors. In N2 status mOS was similar regardless the presence of PALN metastases. The frequency of PALN metastases was similar in PDAC and inv-IPMN. Although PALN positive status entailed a shorter mOS, it was not an independent risk factor for death, and did not influence survival in N2-staged disease. T
Like
Comment
Share
